ADMA Biologics Inc (ADMA)
21.18
-0.12
(-0.56%)
USD |
NASDAQ |
Nov 22, 16:00
21.21
+0.03
(+0.14%)
After-Hours: 20:00
ADMA Biologics Revenue (TTM): 382.81M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 382.81M |
| June 30, 2024 | 330.24M |
| March 31, 2024 | 283.18M |
| December 31, 2023 | 258.22M |
| September 30, 2023 | 234.29M |
| June 30, 2023 | 208.11M |
| March 31, 2023 | 181.89M |
| December 31, 2022 | 154.08M |
| September 30, 2022 | 130.48M |
| June 30, 2022 | 110.07M |
| March 31, 2022 | 94.00M |
| December 31, 2021 | 80.94M |
| September 30, 2021 | 68.52M |
| June 30, 2021 | 58.11M |
| March 31, 2021 | 48.07M |
| December 31, 2020 | 42.22M |
| September 30, 2020 | 40.30M |
| June 30, 2020 | 37.25M |
| March 31, 2020 | 36.02M |
| December 31, 2019 | 29.35M |
| September 30, 2019 | 21.37M |
| June 30, 2019 | 18.38M |
| March 31, 2019 | 16.47M |
| December 31, 2018 | 16.99M |
| Date | Value |
|---|---|
| September 30, 2018 | 24.93M |
| June 30, 2018 | 25.43M |
| March 31, 2018 | 24.17M |
| December 31, 2017 | 22.76M |
| September 30, 2017 | 14.09M |
| June 30, 2017 | 12.29M |
| March 31, 2017 | 11.17M |
| December 31, 2016 | 10.66M |
| September 30, 2016 | 9.846M |
| June 30, 2016 | 8.760M |
| March 31, 2016 | 7.798M |
| December 31, 2015 | 7.178M |
| September 30, 2015 | 6.154M |
| June 30, 2015 | 5.668M |
| March 31, 2015 | 5.858M |
| December 31, 2014 | 5.916M |
| September 30, 2014 | 4.851M |
| June 30, 2014 | 4.592M |
| March 31, 2014 | 3.835M |
| December 31, 2013 | 3.068M |
| September 30, 2013 | 3.167M |
| June 30, 2013 | 2.420M |
| March 31, 2013 | 1.907M |
| December 31, 2012 | 1.118M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
29.35M
Minimum
Dec 2019
382.81M
Maximum
Sep 2024
140.41M
Average
102.03M
Median
Revenue (TTM) Benchmarks
| Corcept Therapeutics Inc | 628.56M |
| Madrigal Pharmaceuticals Inc | -- |
| Assembly Biosciences Inc | 28.33M |
| TG Therapeutics Inc | 264.79M |
| Krystal Biotech Inc | 241.52M |